Strides Pharma to conduct trials in India for potential COVID-19 drug
The Bengaluru-based company has received approval from the Drug Controller General of India to conduct human studies of…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Favipiravir
Brinton Pharmato launch Favipiravir, a promising drug for COVID-19
Favipiravir will be marketed by Brinton Pharmaceuticals under the brand name Faviton and will be available in 200mg and 400mg…
AIIMS Bhopal claims good results in drug trial for COVID-19 treatment
Mycobacterium W was used for the treatment of leprosy and CSIR has tied up with Cadila Pharmaceuticals to evaluate its effect in…
Hikal announces development of Favipiravir APIs and its intermediates
The company is in discussion with potential partners to supply the API and its intermediates
Russia claims Favipiravir shows promise against coronavirus in early trials
Favipiravir is also undergoing trials in India by Glenmark Pharmaceuticals
IICT develops synthetic process for Favipiravir, transfers to Cipla
As a collaborative effort with industry, Hyderabad-based CSIR-IICT transferred the entire process and significant quantities of…
CSIR identifies top 25 drugs/drug candidates for repurposing
Favipiravir, a broad-spectrum inhibitor of viral RNA polymerase, emerges as one of the most promising drugs
Favipiravir exports during COVID-19 outbreak reaffirm India’s position as Pharmacy to the World:…
Favipiravir is the fourth most evaluated repurposed drug after HCQ, lopinavir/ritonavir combination, and recombinant interferon…
Lasa Supergenerics gets FDA nod for progesterone API
Progesterone is one of the 26 drugs that had a restriction for exports due to COVID 19 pandemic as a result of India’s import…
CSIR-IICT ties up with Cipla to develop anti-COVID-19 drug
Research on anti-viral drugs has been on throughout the world for long and many companies have developed molecule shaving…